Nanox Imaging Ltd. (NASDAQ: NNOX) announced that its subsidiary, Nanox AI Ltd., has entered into a sales reseller agreement with Vertec Scientific Ltd. for the commercialization of its AI bone solution, HealthOST, in the United Kingdom. This agreement grants Vertec an exclusive license to market and resell HealthOST in the UK, subject to minimum annual license commitments, for an initial three-year term.
HealthOST is an FDA-cleared and UKCA/CE-marked AI software solution that analyzes eligible routine CT scans to support clinicians in evaluating and assessing musculoskeletal disease of the spine, including osteoporosis. The software is designed to augment the interpretation of routine imaging, potentially enabling earlier detection of chronic conditions without additional radiation exposure or patient burden.
The significance of this agreement is underscored by a recent recommendation from the National Institute for Health and Care Excellence (NICE). In November 2025, NICE recommended HealthOST and a previous version, HealthVCF, among five AI technologies for National Health Service (NHS) use as options to aid opportunistic detection of vertebral fragility fractures. This endorsement could facilitate broader adoption within the NHS, potentially improving patient outcomes and reducing healthcare costs associated with undiagnosed fractures.
The UK market represents a strategic opportunity for Nanox, as the NHS increasingly looks to integrate AI-driven tools to enhance diagnostic accuracy and efficiency. By partnering with Vertec Scientific, a established distributor in the region, Nanox aims to accelerate the availability of HealthOST to healthcare providers across the UK.
For more information on the press release, visit https://ibn.fm/VBSS4.
Nanox is focused on driving the world's transition to preventive healthcare by delivering an integrated, end-to-end medical imaging and healthcare services platform. The company combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The Nanox ecosystem includes Nanox.ARC, a cost-effective 3D multi-source digital tomosynthesis imaging system; Nanox.AI, a suite of AI algorithms that augment interpretation of routine CT imaging; Nanox.CLOUD, a cloud-based platform for secure data management and advanced analytics; Nanox.MARKETPLACE and USARAD Holdings, providing access to remote radiology and cardiology experts; and Nanox Health IT, which delivers RIS, PACS, AI, dictation, and secure infrastructure solutions.
This exclusive UK agreement marks a milestone in Nanox's commercial strategy, leveraging AI to address musculoskeletal diseases that are often underdiagnosed. With NICE's recommendation, HealthOST is positioned to become a standard tool in opportunistic screening, potentially transforming how vertebral fractures are detected in routine clinical practice. The collaboration with Vertec Scientific is expected to streamline distribution and support, ensuring that UK healthcare providers can quickly integrate this innovative solution into their workflows.
